| Symbol | MTNB |
|---|---|
| Name | MATINAS BIOPHARMA HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1545 ROUTE 206 SOUTH,SUITE 302, BEDMINSTER, New Jersey, 07921, United States |
| Telephone | +1 908 484-8805 |
| Fax | — |
| — | |
| Website | https://www.matinasbiopharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001582554 |
| Description | Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firms pipeline includes MAT2203, MAT2501 and others. Additional info from NASDAQ: |
STERN ADAM K 🟡 adjusted position in 2.2M shares (9 derivative) of Matinas BioPharma Holdings, Inc. (MTNB) at $0.64 ($2.1M) Transaction Date: Oct 16, 2025 | Filing ID: 002109
Read moreSanitam Partners LLC 🔴 sold 7.2M shares (2 derivative) of Matinas BioPharma Holdings, Inc. (MTNB) at $0.64 ($4.5M) Transaction Date: Jun 10, 2026 | Filing ID: 002105
Read moreNew Form 425 - Matinas BioPharma Holdings, Inc. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001493152-26-035330 <b>Size:</b> 35 KB
Read moreNew Form 425 - Matinas BioPharma Holdings, Inc. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0001493152-26-035183 <b>Size:</b> 24 KB
Read more(99% Neutral) MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Announces Business Combination
Read moreNew Form 425 - Matinas BioPharma Holdings, Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001493152-26-033590 <b>Size:</b> 24 KB
Read moreMatinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
Read moreNew Form S-3 - Matinas BioPharma Holdings, Inc. <b>Filed:</b> 2026-06-16 <b>AccNo:</b> 0001493152-26-028881 <b>Size:</b> 1 MB
Read moreMatinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Read more